LAURA CORE: Open Payments
NPI 1568893717 · CROSSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 36 payments from 9 companies in 2025. Trend: 2023 $1,340 · 2024 $1,041 · 2025 $1,100
Food & beverage: $968Education: $132
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $297 |
| CSL Behring | 10 | $264 |
| AstraZeneca Pharmaceuticals LP | 5 | $182 |
| GlaxoSmithKline, LLC. | 5 | $100 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $76 |
| PFIZER INC. | 3 | $63 |
| GENZYME CORPORATION | 2 | $44 |
| Pharming Healthcare, Inc. | 1 | $38 |
| Amgen Inc. | 1 | $34 |
Products named: DUPIXENT, Andembry, FASENRA, Hizentra, NUCALA, NEFFY, PANZYGA, TEZSPIRE.
Industry payments across TN — which companies pay providers there.
